TUBB3
Chr 16ADtubulin beta 3 class III
Also known as: CDCBM, CDCBM1, CFEOM3, CFEOM3A, FEOM3, TUBB4, beta-4
This gene encodes beta-tubulin III, a neuron-specific microtubule component that heterodimerizes with alpha-tubulin to form microtubules essential for neurogenesis, axon guidance, and axon maintenance. Autosomal dominant mutations cause congenital fibrosis of extraocular muscles type 3A and cortical dysplasia with other brain malformations. The pathogenic mechanism involves disruption of microtubule assembly and function, leading to abnormal neuronal development and axonal pathfinding.
Definitive — sufficient evidence for diagnostic panels
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly tolerant — LoF variants common in population
Mild missense constraint
The highest-scoring mechanism for this gene is dominant-negative.
Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.
Literature Evidence
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.
ClinVar Variant Classifications
445 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 0 | 15 | 32 | 0 | 47 |
Likely Pathogenic | 0 | 39 | 6 | 0 | 45 |
VUS | 5 | 144 | 27 | 5 | 181 |
Likely Benign | 0 | 6 | 21 | 84 | 111 |
Benign | 0 | 3 | 22 | 5 | 30 |
Conflicting | — | 25 | |||
| Total | 5 | 207 | 108 | 94 | 439 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
TUBB3 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients
ACTIVE NOT RECRUITINGRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
RECRUITINGExternal Resources
Links to major genomics databases and tools